Pharmasset
Latest round
- Series D
Last raised
- Aug 2004
Total raised
- $40M
Investors
- 5
About Pharmasset
Pharmasset, Inc.Founded in 1998 in Princeton, US, Pharmasset, Inc. specializes in antiviral drug development. The company underwent significant changes when it was acquired by Gilead Sciences, Inc.2 billion following a successful IPO in April 2007.Pharmasset, Inc. focuses on developing novel antiviral medications, particularly for hepatitis C and HIV.In the most recent reporting year of 2011, Pharmasset, Inc.Pharmasset, Inc. plans to leverage its recent acquisition by Gilead Sciences to expand its product offerings and market presence. The company aims to enhance its portfolio by developing new antiviral therapies targeting hepatitis C and HIV, with anticipated releases in upcoming years.
Who invested in Pharmasset
5 investors across 1 round
See all investors in Pharmasset
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Aug 10, 2004
Amount
$40M
Investors
Questions about Pharmasset
Who invested in Pharmasset?
Pharmasset has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pharmasset raised?
Pharmasset has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pharmasset last raise money?
Pharmasset's most recent round on record is a Series D, in Aug 2004.
What does Pharmasset do?
Pharmasset is a pharmaceuticals company.
Where is Pharmasset headquartered?
Pharmasset is headquartered in Princeton, US.
Which VCs invest in companies like Pharmasset?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Pharmasset's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Pharmasset? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.